Skip to main content
Top
Published in: Journal of Hematology & Oncology 1/2010

Open Access 01-12-2010 | Letter to the Editor

An epidemiological investigation of leukemia incidence between 2003 and 2007 in Nanjing, China

Authors: Bao-An Chen, Zhi-Hu Huang, Xiao-Ping Zhang, Jian Ou-Yang, Jian-Yong Li, Yong-Ping Zhai, Xue-Mei Sun, Yan-Li Xu, Qin Lu, Jian-Min Wang, Dong Li, Hui Liao, Zhi-Xiang Shen, Yan-Yan Wang, Xiao-Jing Yu, Hui Ye, Li-Ying Zhuang

Published in: Journal of Hematology & Oncology | Issue 1/2010

Login to get access

Abstract

Background

There has been little literature about leukemia epidemiology in Nanjing in recent years. We aimed to explore the incidence rate, gender and age distribution of leukemia in Nanjing using the leukemia database of the city.

Results

The average yearly incidence rate of leukemia was 3.68/105 during 2003 - 2007 in Nanjing. There were no significant difference in gender (x2 = 3.266, p > 0.05) or seasons (x2 = 11.36, p > 0.05). The incidence rate was the highest in group aged 80~ years (18.64/105). AML accounted for approximately 36.8% of all leukemias.

Conclusions

The incidence rate of leukemia, especially in the aged population, was relatively high in Nanjing. Leukemia is the major malignant tumor in children. Therefore, more attention should be paid to leukemia in children and the aged people.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cooperation of entire country leukemia and aplastic anemia epidemiology investigation: Leukemia epidemiology investigation of the entire country. Journal of Chinese Academy of Medical Science. 1992, 14: 12-17. Cooperation of entire country leukemia and aplastic anemia epidemiology investigation: Leukemia epidemiology investigation of the entire country. Journal of Chinese Academy of Medical Science. 1992, 14: 12-17.
2.
go back to reference Wang HW, Pan XD: An Epidemiology analysis of leukemia incidence in Shenyang. Chinese Journal of Prevention and Control Chronic Non-communicable Disease. 2005, 13: 163-164. Wang HW, Pan XD: An Epidemiology analysis of leukemia incidence in Shenyang. Chinese Journal of Prevention and Control Chronic Non-communicable Disease. 2005, 13: 163-164.
3.
go back to reference Chen KX, He M, Dong SF: Study on descriptive epidemiology of leukemia from 1981 to 2000 in Tianjin. Chinese Journal of Oncology. 2004, 31: 424-426. Chen KX, He M, Dong SF: Study on descriptive epidemiology of leukemia from 1981 to 2000 in Tianjin. Chinese Journal of Oncology. 2004, 31: 424-426.
4.
go back to reference Coebergh JW, Reedijk AM, de Vries E, Martos C, Jakab Z, Steliarova-Foucher E, Kamps WA: Leukemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project. European Journal of Cancer. 2006, 42: 2019-2036. 10.1016/j.ejca.2006.06.005.CrossRefPubMed Coebergh JW, Reedijk AM, de Vries E, Martos C, Jakab Z, Steliarova-Foucher E, Kamps WA: Leukemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project. European Journal of Cancer. 2006, 42: 2019-2036. 10.1016/j.ejca.2006.06.005.CrossRefPubMed
5.
go back to reference Meinert R, Kaatsch P, Kaletsch U, Krummenauer F, Miesner A, Michaelis J: Childhood Leukemia and Exposure to Pesticides: Results of a Case-control Study in Northern Germany. European Journal of Cancer. 1996, 32A: 1943-1948. 10.1016/0959-8049(96)00231-6.CrossRefPubMed Meinert R, Kaatsch P, Kaletsch U, Krummenauer F, Miesner A, Michaelis J: Childhood Leukemia and Exposure to Pesticides: Results of a Case-control Study in Northern Germany. European Journal of Cancer. 1996, 32A: 1943-1948. 10.1016/0959-8049(96)00231-6.CrossRefPubMed
6.
go back to reference Petridou E, Dalamaga M, Mentis A: Evidence supporting the infectious aetiology of childhood leukemia: the role of low herd immunity. Cancer Causes Control. 2001, 12: 645-652. 10.1023/A:1011255825887.CrossRefPubMed Petridou E, Dalamaga M, Mentis A: Evidence supporting the infectious aetiology of childhood leukemia: the role of low herd immunity. Cancer Causes Control. 2001, 12: 645-652. 10.1023/A:1011255825887.CrossRefPubMed
7.
go back to reference Smith MA, Ries LAG, Gurney JG: Cancer incidence and survival among children and adolescents: United States SEER Progam 1975-1995. Leukemia. Edited by: Ries LAG, Smith MA, Gurney JG. 1999, NIH Pub. No. 99-4649. Bethesda (MD): National Cancer Institute, SEER Program, 17-34. Smith MA, Ries LAG, Gurney JG: Cancer incidence and survival among children and adolescents: United States SEER Progam 1975-1995. Leukemia. Edited by: Ries LAG, Smith MA, Gurney JG. 1999, NIH Pub. No. 99-4649. Bethesda (MD): National Cancer Institute, SEER Program, 17-34.
8.
go back to reference Xiang D, Shen JX, Huang YZ: Analysis on data of acute leukemia epidemiology in our hospital during 22 years. Journal of Navel General Hospital of P.L.A. 2005, 18: 99-100. Xiang D, Shen JX, Huang YZ: Analysis on data of acute leukemia epidemiology in our hospital during 22 years. Journal of Navel General Hospital of P.L.A. 2005, 18: 99-100.
9.
go back to reference The cooperation group of National leukemia and aplastic anemia epidemiological investigation: The investigation of National leukemia incidence. Acta Academiae Medicine Sinicae. 1992, 14: 12-19. The cooperation group of National leukemia and aplastic anemia epidemiological investigation: The investigation of National leukemia incidence. Acta Academiae Medicine Sinicae. 1992, 14: 12-19.
Metadata
Title
An epidemiological investigation of leukemia incidence between 2003 and 2007 in Nanjing, China
Authors
Bao-An Chen
Zhi-Hu Huang
Xiao-Ping Zhang
Jian Ou-Yang
Jian-Yong Li
Yong-Ping Zhai
Xue-Mei Sun
Yan-Li Xu
Qin Lu
Jian-Min Wang
Dong Li
Hui Liao
Zhi-Xiang Shen
Yan-Yan Wang
Xiao-Jing Yu
Hui Ye
Li-Ying Zhuang
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2010
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/1756-8722-3-21

Other articles of this Issue 1/2010

Journal of Hematology & Oncology 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine